BIOAGE LABS, INC. (BIOA) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $1.16M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $2.65M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $2.00M.
BIOAGE LABS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Fee Amount USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $1.16M | (m) | (m) | (m) | (m) | $500.00K | (m) | $500.00K | (m) |
| 2025-12-31 | $2.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $0.00 | (m) | $2.00M | (m) | (m) | (m) | $2.00M | $2.00K |
| 2025-09-30 | $4.13M | $0.00 | (m) | $2.00M | (m) | $1.50M | (m) | $3.50M | $7.00K |
| 2025-06-30 | $5.60M | $0.00 | (m) | $2.00M | (m) | $3.00M | (m) | $5.00M | $14.00K |
| 2025-03-31 | $6.00M | $1.06M | $7.06M | $2.00M | (m) | $4.50M | (m) | $6.50M | $22.00K |
| 2024-12-31 | $6.00M | $2.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $8.50M | $6.00M | $2.00M | (m) | (m) | $8.00M | $34.00K |
| 2024-09-30 | $6.00M | $3.94M | $9.94M | $6.00M | $2.00M | $1.50M | $487.00K | $9.50M | $47.00K |
| 2023-12-31 | $6.00M | $8.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |